Heat shock proteins, such as HSP40, HSP60, HSP70 and HSP90, are known as molecular chaperones because they play a role in helping proteins function properly when cells are under stress. The heat shock response protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes (the cell’s recycling system), which could otherwise lead to toxicity and disease.
Our work is focused on making use of the cell-protective properties of HSP70 to create new therapies for rare neurodegenerative diseases.
Orphazyme A/S Company announcement No. 33/2022 www.orphazyme.com Company Registration No. 32266355 Copenhagen, Denmark, June 29, 2022 – Orphazyme A/S (ORPHA.CO) (the “Company”), today held its Annual General Meeting, at which the
Orphazyme A/S Company announcement No. 32/2022 www.orphazyme.com Company Registration No. 32266355 NOTICE TO HOLDERS OF AMERICAN DEPOSITARY SHARES (“ADSs”) EVIDENCED BY AMERICAN
Orphazyme A/S Company announcement No. 30/2022 Annual report www.orphazyme.com Company Registration No. 32266355
Our Research
For Investors & Media
Working at Orphazyme